Altered lysophospholipid profiles in plasma and skeletal muscle in type 2 diabetes: sex-specific metabolic signatures
Metabologia · 14.11.2026 · 2 (1)
DOI: 10.1007/s44357-026-00027-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabologia, online erschienen am 14.11.2026. Verfasst von Elin Chorell und 11 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novo Nordisk Fonden, Vetenskapsrådet, Diabetesfonden.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Type 2 diabetes is characterised by aberrant glucose metabolism and additional metabolic changes. This study explores plasma and skeletal muscle metabolite response during transition from fasting to fed following a glucose challenge in individuals with or without type 2 diabetes.
Methods
Mass spectrometry-based metabolomics was performed on skeletal muscle and plasma samples collected under fasting and 2 h into an OGTT from BMI, age, and sex-matched individuals, with either normal glucose tolerance ( N = 42) or type 2 diabetes ( N = 45). Skeletal muscle transcriptome was assessed using an expression array. Links between differentially abundant transcripts and metabolites were investigated using siRNA-mediated gene silencing in cultured human skeletal muscle cells.
Results
Lysophospholipids were the predominant metabolite class in skeletal muscle and plasma discriminating between people with normal glucose tolerance or type 2 diabetes, before and after the glucose challenge. Sex-specific differences in the lysophospholipid response were noted in skeletal muscle, but not plasma. Transcriptomic analysis revealed several genes with altered fasting-state expression in skeletal muscle in a disease-specific manner ( ABCG1 , BDH1 and PCYT2 ). Silencing experiments in cultured muscle identified ABCG1 and BDH1 as modulators of lysophospholipid abundance in cultured human myotubes, with ABCG1 showing sex-dependent effects.
Conclusions
This research identifies metabolic signatures of type 2 diabetes, emphasising the discriminatory role of lysophospholipids in skeletal muscle and plasma. The link between ABCG1 expression and lysophospholipid content may be influenced by biological sex, highlighting the need to explore sex-specific differences in metabolic regulation in type 2 diabetes.
Förderung
- Novo Nordisk Fonden
- Vetenskapsrådet
- Diabetesfonden
Zitieren
APA
Chorell, E., Norman, N. J., Ferreira, D. M. S., Chibalin, A. V., Gao, H., Björnholm, M., Karlsson, H. K. R., Näslund, E., Moritz, T., Katayama, M., Zierath, J. R., & Krook, A. (2026). Altered lysophospholipid profiles in plasma and skeletal muscle in type 2 diabetes: sex-specific metabolic signatures. Metabologia, 2(1). https://doi.org/10.1007/s44357-026-00027-1
Vancouver
Chorell E, Norman NJ, Ferreira DMS, Chibalin AV, Gao H, Björnholm M, et al. Altered lysophospholipid profiles in plasma and skeletal muscle in type 2 diabetes: sex-specific metabolic signatures. Metabologia. 2026;2(1). doi:10.1007/s44357-026-00027-1
BibTeX
@article{Chorell2026,
author = {Chorell, Elin and Norman, Natalie J. and Ferreira, Duarte M. S. and Chibalin, Alexander V. and Gao, Hui and Björnholm, Marie and Karlsson, Håkan K. R. and Näslund, Erik and Moritz, Thomas and Katayama, Mutsumi and Zierath, Juleen R. and Krook, Anna},
title = {Altered lysophospholipid profiles in plasma and skeletal muscle in type 2 diabetes: sex-specific metabolic signatures},
journal = {Metabologia},
year = {2026},
volume = {2},
number = {1},
doi = {10.1007/s44357-026-00027-1}
}
EUVIMED